Clinical Protocol Handbook

SBIRT Protocol Handbook: Universal Screening & Brief Negotiated Interview

Primary care teams identify risky substance use early by pairing a 60-second universal pre-screen with a structured 5-to-15 minute Brief Negotiated Interview and immediate warm handoff.

Clinical Synthesis
Universal annual adult SBIRT uses a two-question pre-screen followed by AUDIT-C or DAST-10 when positive. Scores indicating hazardous use trigger a non-judgmental 5-to-15 minute Feedback-Listen-Options interview paired with a Readiness Ruler, while scores suggesting moderate-to-severe disorder trigger same-day warm handoff and pharmacotherapy evaluation.

Evidence basis: USPSTF Grade B Alcohol Screening Guideline and SAMHSA Systems-Level SBIRT Monograph (SMA 13-4741).

1. Rooming Workflow & Universal Pre-Screen

Targeted screening based on clinical suspicion misses most patients with hazardous drinking or early prescription misuse. Standard outpatient workflows embed two single-item questions into medical assistant intake alongside vital signs for every adult aged 18 or older at least once annually.

  • NIAAA Single-Item Alcohol Pre-Screen: "How many times in the past year have you had 5 or more drinks in a day (for men under 65) or 4 or more drinks in a day (for women and adults 65 or older)?" Any answer of 1 or more times is positive and triggers the 3-item AUDIT-C.
  • NIDA Quick Screen (Single-Item Drug Question): "How many times in the past year have you used an illegal drug or used a prescription medication for non-medical reasons?" Any response greater than zero triggers the DAST-10 or full NIDA-Modified ASSIST.
  • Standard Drink Calibration: Remind patients that one standard drink equals 14 grams of pure alcohol: 12 oz of 5% beer, 5 oz of 12% wine, or 1.5 oz of 80-proof spirits. Large craft pours and cocktails frequently contain 2 to 3 standard drinks.

2. The 4-Step Brief Negotiated Interview (BNI / FLO)

Once AUDIT-C or DAST-10 confirms risky use, confrontational lecturing reliably increases patient defensiveness and resistance. The WIPHL clinical model adapts Motivational Interviewing into a rapid four-step outpatient structure known as FLO (Feedback, Listen and Understand, Options Explored).

  1. Minute 0-1 · Step 1

    Raise the Subject & Ask Permission

    Build autonomy before sharing scores: "Thank you for completing our clinic health questionnaire. Would it be okay if we take five minutes to look at your drinking or substance screen alongside your blood pressure today?"

  2. Minute 1-4 · Step 2

    Provide Objective Medical Feedback

    Connect quantitative screening results directly to the patient's chief complaint without moral judgment: "National health thresholds stay under 7 drinks weekly for women or 14 for men. Your score puts you in a range that can raise systolic blood pressure, disrupt REM sleep, and reduce antidepressant efficacy."

  3. Minute 4-8 · Step 3

    Listen, Reflect & Deploy the Readiness Ruler

    Ask the patient what benefits they experience from current use alongside any concerns. Then ask: "On a scale from 1 to 10, how ready are you to make a change right now?" Follow up by asking why they chose their number instead of a lower one (e.g., "Why a 6 instead of a 2?") to elicit natural change talk.

  4. Minute 8-12 · Step 4

    Explore Options & Close with Warm Handoff

    Summarize the patient's own motivations, co-create one measurable 2-week target (such as alcohol-free weekdays or carrying intranasal naloxone), and offer an immediate hallway introduction to the clinic behavioral health educator or prescribe FDA-approved pharmacotherapy.

3. Clinical Severity Tiers & Escalation Matrix

Clinical Tier Screening Cutoffs Session Duration Pharmacotherapy & Safety Follow-Up Interval
Tier I: Low Risk Pre-screen 0; AUDIT-C <3 F / <4 M; DAST-10 = 0 1-2 min positive reinforcement Verify medication interactions (sedatives, warfarin, metformin) Routine annual preventive re-screen
Tier II: Hazardous Use AUDIT-C 3-7 F or 4-7 M; DAST-10 1-2 5-15 min FLO Brief Intervention Harm reduction; intranasal naloxone if any illicit opioid/stimulant risk 4-8 week primary care follow-up vitals
Tier III: Harmful / Moderate AUDIT-10 16-19; DAST-10 3-5 15-30 min Brief Treatment + Warm Handoff Screen DSM-5 AUD/OUD criteria; discuss oral naltrexone 50 mg daily 7-14 day behavioral health + PCP check
Tier IV: Likely Severe SUD AUDIT-C >=8 or AUDIT-10 >=20; DAST-10 6-10 >30 min Intensive BNI + Same-Day Warm Handoff CIWA-Ar withdrawal check; start naltrexone, acamprosate, or buprenorphine; specialty SUD linkage 48-72 hr bridge call + weekly visits
Primary Care SBIRT to Warm-Handoff Clinical Pathway Primary Care SBIRT and Warm-Handoff Pathway (Target Elapsed Time: 10 to 20 Minutes) STEP 1 · ROOMING Universal Pre-Screen NIAAA single-item alcohol NIDA quick drug screen Negative: affirm & log MA / RN · 60 sec STEP 2 · TRIAGE Validated Instrument AUDIT-C (>=3 F / >=4 M) DAST-10 (>=3 moderate+) Readiness Ruler (1-10) PCP / Resident · 3 min STEP 3 · INTERVENTION Brief Negotiated FLO Feedback on labs/vitals Listen to ambivalence Options + CPT 99408 Clinician · 5 to 15 min STEP 4 · HANDOFF Warm Handoff Live intro in exam room to PCBH peer MAT / SUD linkage >80% Same-Day

4. Interactive BNI Script & Readiness Generator

FLO Outpatient Script Builder

FLO Elicit Change Talk
Select Clinical Encounter Scenario
Patient Readiness Ruler Rating (1-10)
AUDIT-C 6/12

5. Primary Care Pharmacotherapy Bridge

Behavioral interventions achieve higher durability when primary care clinicians do not defer medication-assisted treatment solely to external specialty centers. For uncomplicated moderate-to-severe alcohol use disorder without acute decompensated cirrhosis, oral naltrexone 50 mg once daily (after verifying opioid-free status) reduces heavy drinking days, while acamprosate 666 mg three times daily supports abstinence in patients with hepatic transaminitis or renal clearance eGFR > 50 mL/min.

For opioid use disorder, primary care clinics can initiate home or office buprenorphine-naloxone induction alongside intranasal naloxone 4 mg rescue kits and connect the patient through a same-day behavioral health warm handoff. Confirm billing time capture using the SBIRT coding and reimbursement guide.

6. Protocol Questions

How long does a standard primary care Brief Negotiated Interview take?

A focused Brief Negotiated Interview using the Feedback, Listen, and Options framework takes 5 to 15 minutes inside a routine outpatient visit and qualifies for CPT 99408 or HCPCS G0396 once cumulative counseling reaches 15 minutes.

Which medications can primary care clinicians initiate directly after a positive SBIRT screen?

Primary care physicians and advanced practice clinicians can prescribe oral naltrexone, extended-release injectable naltrexone, or acamprosate for moderate-to-severe alcohol use disorder, and buprenorphine-naloxone for opioid use disorder without a special X-waiver.

Historical Citation Context: SAMHSA SMA 13-4741 Operational SBIRT Manual

Legacy Cited Path: /uploads/media/SBIRT_Manual.pdf

Preserved for academic citation continuity from SAMHSA Publication SMA 13-4741 ("Systems-Level Implementation of Screening, Brief Intervention, and Referral to Treatment," p. 55), which referenced the original Wisconsin Initiative to Promote Healthy Lifestyles operational SBIRT training manual. This handbook page preserves the core FLO brief intervention sequence while integrating 2026 USPSTF screening intervals and primary care MOUD workflows.